
About IHI
At the Innovative Hematology (IHI), we offer a future where people with rare blood disorders flourish. Our experts provide the highest quality comprehensive services and holistic care to patients with bleeding, clotting and other hematologic disorders, and to their families.
What You Will Do
As Clinical Education Program Coordinator for the Partners Program ("Partners Program Coordinator"), you will be responsible for supporting the execution of the Partners in Bleeding Disorders Education Program ("Partners"). This role is specifically responsible for planning and executing educational project and training activities and working collaboratively with the Partners Program Team to ensure successful educational initiatives meet continuing education (CE) standards and serve the education needs of the U.S. Hemophilia Treatment Center (HTC) network.
The Partners in Bleeding Disorders Education Program promotes excellence in care through education created by and for the U.S. Hemophilia Treatment Center (HTC) network and providers from a variety of disciplines that serve patients with bleeding and other coagulation disorders. The Partners Program aims to cultivate a national workforce of HTC clinical providers who are knowledgeable, competent, and capable of full participation on the multidisciplinary hemophilia comprehensive care team providing integrated care that reflects evidence-based standards and best practice for treatment of persons with bleeding disorders. The program provides accredited in-person, virtual, and online learning activities that target HTC clinical providers. The Partners Program offers a catalog of introductory and advanced educational opportunities targeting the multidisciplinary hemophilia comprehensive care team, including but not limited to, physicians, nurses, advanced practice providers, physical therapists, social workers, among others. Partners programs cover benign hematological disorders including hemophilia A and B, von Willebrand disease (VWD), rare bleeding disorders, platelet disorders, thrombosis/thrombophilia, and other inheritable conditions marked by excessive bleeding and/or clotting.
The Opportunity
This position is designed to be a hybrid role, splitting time between the IHI office in Indianapolis, IN and home. For employees not located in the Indianapolis metro area, occasional travel to the Center for Partners-specific activities is required.
Occasional travel required for any employee in this role for applicable meetings or team-specific needs.
Requirements
Benefits
IHI is a not-for-profit program based in Indianapolis and offers a competitive salary and benefit package.
IHI is the only federally designated comprehensive hemophilia program in Indiana, and serves the entire state through services available in Indianapolis and at outreach clinics.
IHI is a leader in hemophilia care, education and clinical research and has a dedicated on-site multidisciplinary staff to ensure availability of a wide range of required services.
IHI participates in national and international clinical research, including new infusion products and therapies, investigation of long-term outcomes, and the impact of associated conditions. The IHTC research program provides patients access to new therapies, and an opportunity to improve care. Our center has more than 50 clinical research projects involving bleeding disorders, sickle cell disease, thrombosis and more.
Innovative Hematology, Inc. is an Equal Opportunity Employer.

Innovative Hematology, Inc. treats blood disorders—from common to rare—every day. Innovative Hematology is a certified medical home recognized for excellence in comprehensive patient-centered health care.
Innovative Hematology is home to the Indiana Hemophilia and Thrombosis Center (also known as the IHTC, a 501(c)3), one of the nation’s top federally recognized hemophilia treatment centers, where we treat hemophilia, von Willebrand disease, and other rare bleeding and clotting conditions. Innovative Hematology also treats sickle cell disease, thalassemia, and other blood disorders such as HHT and nutritional anemias.
Innovative Hematology is both nationally and internationally distinguished as a Center of Excellence for its leadership in blood disorder patient care, education and research.